Recent

% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

drumss11 9 posts  |  Last Activity: Feb 5, 2016 10:33 AM Member since: May 15, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    MU will be $8 in two weeks

    by shirpelang Feb 5, 2016 9:07 AM
    drumss11 drumss11 Feb 5, 2016 10:33 AM Flag

    Feb. qtr. earnings will most likely take us low $9's and maybe lower. Forward guidance will kill us this year. I look to back up the truck at that point. This stock has been strong of late holding in a tight range no matter what the Dow does.

    Sentiment: Hold

  • drumss11 by drumss11 Feb 1, 2016 4:09 PM Flag

    Goldman upped to neutral from sell today - lowered target price to $11 from $13. I better get in before this move.

  • Reply to

    Keep your chin up dumb retail loser longs...

    by jctuttle14 Jan 28, 2016 10:59 AM
    drumss11 drumss11 Jan 28, 2016 11:11 AM Flag

    MU short interest increased quit a bit last month - they could have some control here. I'm still looking to add somewhere in the $8's when this market finally decides to wash out or some say flush. There will be some tremendous bargains on that day.

    Sentiment: Hold

  • Cramer said it's to early to buy MU - I'm kind of hoping he's right as I missed the low yesterday to add. Wouldn't doubt he's right though - this downside market is not done yet IMHO - in fact I think we could see some scary things/levels before this is over.

    Sentiment: Hold

  • I see these simple catalysts and is most likely the reason for Jim Cramer's love for RDUS as the reason we go above $100.00 in late 2016. Of course we will need a better market that IMO is coming by spring.

    Small float - only 43 million shares outstanding with a high percentage owned by insiders and institutions. Not a lot of supply out there when things start to happen.

    500+ million in cash with no debt. No reason to offer additional shares for a long period - if ever. They have over $11.50 a share in cash.

    FDA and EU approvals coming in 2016. Pipeline expansion becomes evident after approvals.

    A sleeper buy at $50+ and with some patients we see $70 to $80 by summer end and $100+ by year end.

    I like our chances here my friends5 - textbook buy and hold.

    Sentiment: Strong Buy

  • drumss11 by drumss11 Dec 10, 2015 12:40 PM Flag

    Be sure to dial in on the conf. call tonight at 8 p.m. Friday will be the turn that refreshes. With only 43 million shares outstanding and 400 to 500 million in cash with no debt RDUS will go considerable higher in the near future. Textbook buy and hold in here my friends.

  • drumss11 by drumss11 Nov 17, 2015 2:54 PM Flag

    43 million shares outstanding for Radius. This is extremely low and puts us on the buyout list for many large pharma's. See all longs at the bank in due time. Textbook.

    Sentiment: Strong Buy

  • drumss11 by drumss11 Nov 11, 2015 9:51 AM Flag

    Alibaba says all high end products where sold out yesterday. So much for GOPRO inventory. We go higher my friends.

    Sentiment: Strong Buy

  • drumss11 by drumss11 Nov 9, 2015 11:36 AM Flag

    Overall market is down big and Gopro is up. Possible buyout or positive company news is on the way. Some of the shorts must be aware of what's coming and they are running. Very unusual pps action today on this very negative day. Textbook buy.

    Sentiment: Strong Buy

ALNY
65.59-1.92(-2.84%)Feb 5 4:00 PMEST